Precision BioSciences Inc. (NASDAQ: DTIL) stock closed at 0.7 per share at the end of the most recent trading day (a -5.37% change compared to the prior day closing price) with a volume of 589.31K shares and market capitalization of 77.91M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 223 people. Precision BioSciences Inc. CEO is Matthew Kane.

The one-year performance of Precision BioSciences Inc. stock is -77.65%, while year-to-date (YTD) performance is -41.18%. DTIL stock has a five-year performance of %. Its 52-week range is between 0.715 and 3.44, which gives DTIL stock a 52-week price range ratio of -0.55%

Precision BioSciences Inc. currently has a PE ratio of -0.90, a price-to-book (PB) ratio of 1.79, a price-to-sale (PS) ratio of 9.57, a price to cashflow ratio of 521.80, a PEG ratio of 2.32, a ROA of -45.43%, a ROC of -94.62% and a ROE of -123.82%. The company’s profit margin is -41.15%, its EBITDA margin is -458.50%, and its revenue ttm is $14.50 Million , which makes it $0.13 revenue per share.

Of the last four earnings reports from Precision BioSciences Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.22 for the next earnings report. Precision BioSciences Inc.’s next earnings report date is 08th May 2023.

The consensus rating of Wall Street analysts for Precision BioSciences Inc. is Moderate Buy (1.8), with a target price of $7.8, which is +1 014.29% compared to the current price. The earnings rating for Precision BioSciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Precision BioSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Precision BioSciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 12.09, ATR14 : 0.08, CCI20 : -133.18, Chaikin Money Flow : -0.26, MACD : -0.11, Money Flow Index : 26.61, ROC : -39.13, RSI : 23.76, STOCH (14,3) : 1.65, STOCH RSI : 0.00, UO : 34.02, Williams %R : -98.35), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Precision BioSciences Inc. in the last 12-months were: Alan List (Option Excercise at a value of $0), Alan List (Sold 17 248 shares of value $26 464 ), Dario Scimeca (Option Excercise at a value of $0), Dario Scimeca (Sold 22 005 shares of value $33 280 ), Derek Jantz (Option Excercise at a value of $0), Derek Jantz (Sold 18 849 shares of value $38 829 ), Jeff Smith (Option Excercise at a value of $0), John Alexander Kelly (Buy at a value of $127 592), John Alexander Kelly (Option Excercise at a value of $0), Michael Amoroso (Option Excercise at a value of $0), Michael Amoroso (Sold 58 005 shares of value $53 067 ), Shane Barton (Option Excercise at a value of $0)